Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical L-006,235, Purity: ≥98%, CAS: 294623-49-7, 25 mg
SDP

Catalog No. 502937184
Encompass_Preferred

An orally bioavailable reversible inhibitor of cathepsin K (Ki(app) = 0.2 nM); selective for cathepsin K over cathepsins B, -L, and -S (Ki(app) = 1, 6, and 47 µM, respectively); inhibits degradation of bovine bone by isolated rabbit osteoclasts (IC50 = 5 nM); reduces loss of lumbar vertebral bone mineral density by 13.3% in ovariectomized rabbits at 10 mg/kg for 27 days; increases weight bearing, indicating analgesia, in a rat model of osteoarthritis pain at 100 mg/kg

Catalog No. 50-293-7184 Supplier Cayman Chemical Supplier No. 2884325 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

An orally bioavailable reversible inhibitor of cathepsin K (Ki(app) = 0.2 nM); selective for cathepsin K over cathepsins B, -L, and -S (Ki(app) = 1, 6, and 47 µM, respectively); inhibits degradation of bovine bone by isolated rabbit osteoclasts (IC50 = 5 nM); reduces loss of lumbar vertebral bone mineral density by 13.3% in ovariectomized rabbits at 10 mg/kg for 27 days; increases weight bearing, indicating analgesia, in a rat model of osteoarthritis pain at 100 mg/kg

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.